Liu KS et al. |
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial. |
2014 |
Gut |
pmid:24295850
|
Katayama M et al. |
Preliminary study of effects of multiple oral dosing of clarithromycin on the pharmacokinetics of cyclosporine in dogs. |
2014 |
J. Vet. Med. Sci. |
pmid:24189617
|
Papastergiou V et al. |
Current and future insights in H. pylori eradication regimens: the need of tailoring therapy. |
2014 |
Curr. Pharm. Des. |
pmid:24180408
|
Tan X and Song Z |
Human saliva-based quantitative monitoring of clarithromycin by flow injection chemiluminescence analysis: a pharmacokinetic study. |
2014 |
Appl. Biochem. Biotechnol. |
pmid:24166104
|
Kakuda TN et al. |
Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies. |
2014 |
J. Antimicrob. Chemother. |
pmid:24155058
|
Seung KJ et al. |
Salvage therapy for multidrug-resistant tuberculosis. |
2014 |
Clin. Microbiol. Infect. |
pmid:23991934
|
Kathariya R et al. |
Evaluation of subgingivally delivered 0.5% clarithromycin as an adjunct to nonsurgical mechanotherapy in the management of chronic periodontitis: a short-term double blinded randomized control trial. |
2014 |
J Investig Clin Dent |
pmid:23097216
|
Shahbazi Niaz M et al. |
Investigation into physical-chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles. |
2014 |
Pharm Dev Technol |
pmid:24093825
|
Maev IV et al. |
[Eradication therapy for Helicobacter pylori infection: review of world trends]. |
2014 |
Ter. Arkh. |
pmid:24779078
|
Katagiri S et al. |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia]. |
2014 |
Nippon Naika Gakkai Zasshi |
pmid:24796145
|
Kato M |
[Expanded indication of National Health Insurance for H. pylori associated gastritis]. |
2014 |
Nippon Rinsho |
pmid:24912302
|
Bjerre M et al. |
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. |
2014 |
Scand. J. Clin. Lab. Invest. |
pmid:25026506
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Tsovolou EC et al. |
Effect of clarithromycin in experimental empyema by multidrug-resistant Pseudomonas aeruginosa. |
2014 |
APMIS |
pmid:23656439
|
Altman E et al. |
Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori. |
2014 |
Can. J. Microbiol. |
pmid:24392924
|
Kim SY et al. |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease. |
2014 |
Clin. Exp. Immunol. |
pmid:24354934
|
De Francesco V et al. |
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. |
2014 |
J. Med. Microbiol. |
pmid:24344205
|
Yamada K et al. |
Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cells. |
2014 |
Pulm Pharmacol Ther |
pmid:24910464
|
Page SR and Yee KC |
Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin. |
2014 |
Intern Med J |
pmid:25041770
|
Methaneethorn J et al. |
A pharmacokinetic drug-drug interaction model of simvastatin and clarithromycin in humans. |
2014 |
Conf Proc IEEE Eng Med Biol Soc |
pmid:25571290
|
El-Garem Y et al. |
Seminal Helicobacter pylori treatment improves sperm motility in infertile asthenozoospermic men. |
2014 |
Urology |
pmid:25432826
|
Kim SY et al. |
[Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication]. |
2014 |
Korean J Gastroenterol |
pmid:25420735
|
Mustafa G and Necati B |
Clarithromycin-associated rhabdomyolysis in an infant. |
2014 |
J Clin Rheumatol |
pmid:25417692
|
Yangco BG et al. |
Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART? |
2014 |
AIDS Patient Care STDS |
pmid:24833016
|
Martos M et al. |
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions. |
2014 |
Eur J Gastroenterol Hepatol |
pmid:25229983
|
Veraldi S et al. |
Treatment of sporotrichoid fish tank granuloma with pulsed clarithromycin. |
2014 |
Dermatology (Basel) |
pmid:25228273
|
Phillips RO et al. |
Reply to "compliance with antimicrobial therapy for buruli ulcer". |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225343
|
Klis S et al. |
Compliance with antimicrobial therapy for buruli ulcer. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25225342
|
Hsu PI et al. |
Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25070099
|
Patel SK et al. |
Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study. |
2014 |
Biomed Res Int |
pmid:25054141
|
Elkhatib W and Noreddin A |
Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model. |
2014 |
Microb. Drug Resist. |
pmid:25050970
|
Ohe M and Bohgaki T |
Successful treatment with clarithromycin for patients with polymyalgia rheumatica. |
2014 |
Korean J. Intern. Med. |
pmid:25045305
|
Martin JH and Coombes I |
Mortality from common drug interactions systems, knowledge and clinical reasoning to optimise prescribing. |
2014 |
Intern Med J |
pmid:25041768
|
Dalbøge CS et al. |
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. |
2014 |
J. Cyst. Fibros. |
pmid:24035278
|
Sugimoto M and Furuta T |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. |
2014 |
World J. Gastroenterol. |
pmid:24914361
|
Heo J and Jeon SW |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:24914324
|
Glatz M and Muellegger RR |
Drug-associated aquagenic wrinkling of the palms in an atopic male patient. |
2014 |
BMJ Case Rep |
pmid:24903725
|
DiCicco M et al. |
In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius. |
2014 |
BMC Microbiol. |
pmid:24886369
|
Noonan KA et al. |
Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma. |
2014 |
Cancer Immunol Res |
pmid:24878583
|
Gong EJ et al. |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? |
2014 |
J. Korean Med. Sci. |
pmid:24851029
|
Jeon HK and Kim GH |
Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea? |
2014 |
J. Korean Med. Sci. |
pmid:24851014
|
Ikawa K et al. |
Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages. |
2014 |
J Clin Pharm Ther |
pmid:24661290
|
Varvyanskaya A and Lopatin A |
Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. |
2014 |
Int Forum Allergy Rhinol |
pmid:24659566
|
Lee SH et al. |
Detection and assessment of clarithromycin inducible resistant strains among Korean Mycobacterium abscessus clinical strains: PCR methods. |
2014 |
J. Clin. Lab. Anal. |
pmid:24652818
|
Binh TT et al. |
Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. |
2014 |
J. Antimicrob. Chemother. |
pmid:24648504
|
Tursi A et al. |
Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study. |
2014 |
Panminerva Med |
pmid:24637473
|
Wei Z et al. |
Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients. |
2014 |
Helicobacter |
pmid:24617669
|
Wu JY et al. |
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. |
2014 |
Helicobacter |
pmid:24612093
|
Settin A et al. |
Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. |
2014 |
Indian J Gastroenterol |
pmid:24610583
|
Zhang J et al. |
Ocular penetration and pharmacokinetics of topical clarithromycin eye drops to rabbits. |
2014 |
J Ocul Pharmacol Ther |
pmid:24199739
|